Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 70

Sort by

Sort Order Select

Journal Articles

Modulation of the IL-6/STAT3 Signaling Axis in CD4 + T Cells As a Potential Immune Mechanism of Action of Azacytidine in High-Risk Myelodysplastic Syndromes

Eleftheria Lamprianidou, Chrysoula Kordella, Anastasiya Kazachenka, Emmanouela Zoulia, Elsa Bernard, PhD, Anastasia Filia, Stamatia Laidou, Theodoros P. Vassilakopoulos, MD PhD, Sotirios Papageorgiou, MD PhD, Vassiliki Pappa, MD, Athanasios Galanopoulos, MD PhD, Nora-Athina Viniou, MD PhD, Evangelia Nakou, Anastasia Hadzidimitriou, PhD, George Kassiotis, Elli Papaemmanuil, PhD, Ioannis Mitroulis, Ioannis Kotsianidis

Blood (2019) 134 (Supplement_1): 2988.

https://doi.org/10.1182/blood-2019-126504

Published: 2019

Journal Articles

A Phase II Study of Lenalidomide Plus Rituximab in Patients with Newly Diagnosed Follicular Lymphoma: An Interim Analysis

Zhong Zheng, Li Wang, MD PhD, Shu Cheng, Pengpeng Xu, Weili Zhao, MD PhD

Blood (2019) 134 (Supplement_1): 3984.

https://doi.org/10.1182/blood-2019-126667

Published: 2019

Journal Articles

Stim1 Deletion Synthetically Rescues Ezh2-Null Effector T Cells and Alloimmunity

Ying Wang, PhD, Shan He, PhD, Yongnian Liu, Robert Hooper, PhD, Hongshuang Yu, Yuanyuan Tian, Hongxing Sun, PhD, Ran Reshef, MD MSc, Elizabeth O. Hexner, MD MS, Jonathan Soboloff, Yi Zhang, MD

Blood (2018) 132 (Supplement 1): 4533.

https://doi.org/10.1182/blood-2018-99-118720

Published: 2018

Journal Articles

ABT-199 (venetoclax) Synergizes Cytotoxicity of Cytotoxic T-Cell (CTL) to B-Cell Lymphomas

Satsuki Murakami, MD, Susumu Suzuki, PhD, Ichiro Hanamura, MD PhD, Kazuhiro Yoshikawa, PhD, Ryuzo Ueda, MD PhD, Akiyoshi Takami, MD

Blood (2018) 132 (Supplement 1): 5154.

https://doi.org/10.1182/blood-2018-99-117471

Published: 2018

Journal Articles

Notch Activation Rescues Exhaustion in CISH -Deleted Human iPSC-Derived Natural Killer Cells to Promote In Vivo Persistence and Enhance Anti-Tumor Activity

Huang Zhu, PhD, Robert Blum, Zhengming Wu, Andres Bahena, Hanna Julie Hoel, Eivind Heggernes Ask, Kun-Liang Guan, PhD, Karl-Johan Malmberg, MD PhD, Dan S Kaufman, MDPhD

Blood (2018) 132 (Supplement 1): 1279.

https://doi.org/10.1182/blood-2018-99-112791

Published: 2018

Journal Articles

Mechanisms of CD4 T Cell Tumor Immunity in a Preclinical Model of Multiple Myeloma

Selma Bekri, PhD, Reunet Rodney-Sandy, BS, Diana Gruenstein, BS, Bjarne Bogen, MD PhD, Daniel Levey, PhD, Hearn Jay Cho, MD

Blood (2018) 132 (Supplement 1): 1947.

https://doi.org/10.1182/blood-2018-99-117129

Published: 2018

Journal Articles

A Novel Role for Histone Deacetylase 10 (HDAC10) in the Regulation of PD-L1 Expression and Immune Tolerance Mediated By Antigen Presenting Cells (APCs)

Michael Wang, Bachelor of Science, Fengdong Cheng, MD, Jie Chen, PhD, Yixuan Li, PhD, Alejandro Villagra, PhD, Mitchell R. Smith, MD PhD, Edward Seto, PhD, Eduardo Martin Sotomayor, MD

Blood (2017) 130 (Supplement 1): 3561.

https://doi.org/10.1182/blood.V130.Suppl_1.3561.3561

Published: 2017

Journal Articles

Mechanisms Linking Fibrin(ogen) Structure/Function to Tumor Metastasis

Allison S. Remiker, MD, Leah A. Rosenfeldt, BS, Greg N. Adams, PhD, Matthew J. Flick, PhD, Malinda D. Frederick, BS, Joseph S. Palumbo, MD

Blood (2017) 130 (Supplement 1): 1063.

https://doi.org/10.1182/blood.V130.Suppl_1.1063.1063

Published: 2017

Journal Articles

PD-1 Expression in Chronic Lymphocytic Leukemia and Large B-Cell Richter Transformation (DLBCL-RT): A Distinguishing Feature for DLBCL-RT and Promising Surrogate Marker for Clonal Relatedness

Rong He, MD, Wei Ding, MD PhD, David Viswanatha, MD, Dong Chen, MD PhD, Min Shi, MD PhD, Daniel L. Van Dyke, PhD, Linda N Dao, MD, Sameer A. Parikh, MD, Tait D Shanafelt, MD, Timothy G. Call, MD, Stephen M Ansell, MD PhD, Jose F. Leis, MD PhD, Ming Mai, MS, Curtis A. Hanson, MD, Karen L Rech, MD

Blood (2017) 130 (Supplement 1): 4286.

https://doi.org/10.1182/blood.V130.Suppl_1.4286.4286

Published: 2017

Journal Articles

Biology of PD-1 Checkpoint Blockade

Arlene H. Sharpe, MD PhD

Blood (2017) 130 (Supplement 1): SCI-35.

https://doi.org/10.1182/blood.V130.Suppl_1.SCI-35.SCI-35

Published: 2017

Journal Articles

Novel Subtypes Based on Microenvironment Immune Signature Provides Prognostic Stratification and Therapeutic Strategy in Peripheral T-Cell Lymphoma

Takeshi Sugio, MD, Kohta Miyawaki, MD, Kensuke Sasaki, MD, Koji Kato, MD PhD, Hiroaki Miyoshi, MDPhD, Koichi Ohshima, MDPhD, Takahiro Maeda, Koichi Akashi, MD PhD

Blood (2017) 130 (Supplement 1): 1453.

https://doi.org/10.1182/blood.V130.Suppl_1.1453.1453

Published: 2017

Journal Articles

A p53-MDM2 Interaction Inhibitor, DS-5272, Inhibits the Development of MLL-Fusion Leukemia with the Assistance of Tumor Immunity

Susumu Goyama, MD PhD, Yasutaka Hayashi, XiaoXiao Liu, Shiori Shikata, Yosuke Tanaka, Tomofusa Fukuyama, MD PhD, Akiko Matsumoto, Satoshi Yamasaki, Tatsuhiro Shibata, Toshio Kitamura, MD PhD

Blood (2017) 130 (Supplement 1): 796.

https://doi.org/10.1182/blood.V130.Suppl_1.796.796

Published: 2017

Journal Articles

Amlexanox As a Possible Breakthrough Drug for MLL/AF4 -Positive Acute Lymphoblastic Leukemia

Hayato Tamai, MD PhD, Hiroki Yamaguchi, MD PhD, Koichi Miyake, MD PhD, Miyuki Takatori, Tomoaki Kitano, Syunsuke Yui, MD, Keiko Fukunaga, MD, Kazutaka Nakayama, MD PhD, Koiti Inokuchi, PhD MD

Blood (2016) 128 (22): 1590.

https://doi.org/10.1182/blood.V128.22.1590.1590

Published: 2016

Journal Articles

In Vitro Induction of Human Regulatory T-Cells (iTregs) Using Conditions of Low Tryptophan Plus Kynurenines

Keli L. Hippen, PhD, Margaret L. MacMillan, MD, Amanda Lemire, BS, Asim Saha, PhD, Eric Hanse, Colin Lord, Ameeta Kelekar, PhD, Roddy S. O'Connor, PhD, James L. Riley, PhD, Carl H June, MD, Leslie Kean, MD PhD, Jeffrey S. Miller, MD, John E. Wagner, MD, David H. Munn, MD, Bruce R. Blazar, MD

Blood (2016) 128 (22): 1229.

https://doi.org/10.1182/blood.V128.22.1229.1229

Published: 2016

Journal Articles

Distinct Patterns of PD-L1 and PD-L2 Expression By Tumor and Non-Tumor Cells in Patients with MM, MDS and AML

Monique Dail, Long Yang, Cherie Green, Connie Ma, Alberto Robert, Edward E. Kadel, Harmut Koeppen, Joanne Adamkewicz, John Byon, Joseph Woodard, Scott J Rodig, Jeffrey M Venstrom

Blood (2016) 128 (22): 1340.

https://doi.org/10.1182/blood.V128.22.1340.1340

Published: 2016

Journal Articles

Intratumoral G100 Rescues Radiation-Induced T Cell Depletion and Has Synergistic Anti-Tumor Effect with Local Irradiation in A20 Lymphoma

Hailing Lu, MD PhD, Eric Ford, PhD, Jeffrey L Schwartz, PhD, Jessica Hewitt, Frank J Hsu, MD, Jan ter Meulen, MD, Ramesh Rengan, MD PhD

Blood (2016) 128 (22): 4166.

https://doi.org/10.1182/blood.V128.22.4166.4166

Published: 2016

Journal Articles

Circulating CD2 Negative T Cells in Pediatric Acute Leukemia

Weijie Li, MD, Lei Shao, MD, Atif Ahmed, MD, Doug Myers, MD, Keith J August, MD MS

Blood (2016) 128 (22): 5151.

https://doi.org/10.1182/blood.V128.22.5151.5151

Published: 2016

Journal Articles

A CD47xCD19 Bispecific Antibody That Remodels the Tumor Microenvironment for Improved Killing and Provokes a Memory Immune Response to Cancer B Cells

Walter G. Ferlin, PhD, Xavier Chauchet, PhD PharmD, Vanessa Buatois, PhD, Susana Salgado-Pires, PhD, Limin Shang, PhD, Elie Dheilly, MSc, Krzysztof Masternak, PhD, Zoë Johnson, PhD, John F DiPersio, MD PhD, Julie Ritchey, Linda Eissenberg, PhD, Marie H. Kosco-Vilbois, PhD, Nicolas Fischer, PhD

Blood (2016) 128 (22): 44.

https://doi.org/10.1182/blood.V128.22.44.44

Published: 2016

Journal Articles

MYd88 Blockade Caused Reduction of PDL1 on Tumor Infiltrating MDSCs in a Murine Model of Melanoma

Parvin Forghani, PhD of Immunology, Edmund K Waller, MD PhD

Blood (2015) 126 (23): 1012.

https://doi.org/10.1182/blood.V126.23.1012.1012

Published: 2015

Journal Articles

IL-33/ST2 Triggering of IL-9-Secreting T Cells Alters the Balance of Fatal Immunity and Tumor Immunity

Abdulraouf Ramadan, PhD, Jilu Zhang, PhD, Mohammad Abu Zaid, MD, Heather O'Leary, PhD, Reuben Kapur, PhD, Helmut Hanenberg, MD, Jie Sun, PhD, Hal E. Broxmeyer, PhD, Mark H. Kaplan, PhD, Sophie Paczesny, MD PhD

Blood (2015) 126 (23): 231.

https://doi.org/10.1182/blood.V126.23.231.231

Published: 2015

NARROW

Modulation of the IL-6/STAT3 Signaling Axis in CD4 + T Cells As a Potential Immune Mechanism of Action of Azacytidine in High-Risk Myelodysplastic Syndromes

A Phase II Study of Lenalidomide Plus Rituximab in Patients with Newly Diagnosed Follicular Lymphoma: An Interim Analysis

Stim1 Deletion Synthetically Rescues Ezh2-Null Effector T Cells and Alloimmunity

ABT-199 (venetoclax) Synergizes Cytotoxicity of Cytotoxic T-Cell (CTL) to B-Cell Lymphomas

Notch Activation Rescues Exhaustion in CISH -Deleted Human iPSC-Derived Natural Killer Cells to Promote In Vivo Persistence and Enhance Anti-Tumor Activity

Mechanisms of CD4 T Cell Tumor Immunity in a Preclinical Model of Multiple Myeloma

A Novel Role for Histone Deacetylase 10 (HDAC10) in the Regulation of PD-L1 Expression and Immune Tolerance Mediated By Antigen Presenting Cells (APCs)

Mechanisms Linking Fibrin(ogen) Structure/Function to Tumor Metastasis

PD-1 Expression in Chronic Lymphocytic Leukemia and Large B-Cell Richter Transformation (DLBCL-RT): A Distinguishing Feature for DLBCL-RT and Promising Surrogate Marker for Clonal Relatedness

Biology of PD-1 Checkpoint Blockade

Novel Subtypes Based on Microenvironment Immune Signature Provides Prognostic Stratification and Therapeutic Strategy in Peripheral T-Cell Lymphoma

A p53-MDM2 Interaction Inhibitor, DS-5272, Inhibits the Development of MLL-Fusion Leukemia with the Assistance of Tumor Immunity

Amlexanox As a Possible Breakthrough Drug for MLL/AF4 -Positive Acute Lymphoblastic Leukemia

In Vitro Induction of Human Regulatory T-Cells (iTregs) Using Conditions of Low Tryptophan Plus Kynurenines

Distinct Patterns of PD-L1 and PD-L2 Expression By Tumor and Non-Tumor Cells in Patients with MM, MDS and AML

Intratumoral G100 Rescues Radiation-Induced T Cell Depletion and Has Synergistic Anti-Tumor Effect with Local Irradiation in A20 Lymphoma

Circulating CD2 Negative T Cells in Pediatric Acute Leukemia

A CD47xCD19 Bispecific Antibody That Remodels the Tumor Microenvironment for Improved Killing and Provokes a Memory Immune Response to Cancer B Cells

MYd88 Blockade Caused Reduction of PDL1 on Tumor Infiltrating MDSCs in a Murine Model of Melanoma

IL-33/ST2 Triggering of IL-9-Secreting T Cells Alters the Balance of Fatal Immunity and Tumor Immunity

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only